ÆÈ·Î¿ì
Keon Wook Kang
Keon Wook Kang
snu.ac.krÀÇ À̸ÞÀÏ È®ÀεÊ
Á¦¸ñ
Àοë
Àοë
¿¬µµ
Comparison of the results for sentinel lymph node mapping in the breast cancer patients using 99mTc-antimony trisulfide colloid, 99mTc-tin colloid, and 99mTc-human serum albumin
SJ Jang, SH Moon, SK Kim, BS Kim, SW Kim, KW Chung, ES LEE, ...
Nuclear Medicine and Molecular Imaging, 546-552, 2007
102007
¡®ºÎÀ¯¡¯°¨³ª¹«ÀÇ ¼ö·É¿¡ µû¸¥ ¼öü »ýÀå°ú ¼ö·® º¯È­
ÃÖ¼ºÅ£¬ ÃÖÀçÇõ£¬ Á¶¿ëÁ¶£¬ ½ÅÇö¿­£¬ °­¼º¸ð
¿ø¿¹°úÇбâ¼úÁö 27 (3), 386-390, 2009
22009
¼¶À¯È¥ÀÔ·üÀÌ ÃÊ°í°­µµ °­¼¶À¯ º¸°­ ÄÜÅ©¸®Æ®ÀÇ ÀÎÀ忬ȭ°Åµ¿¿¡ ¹ÌÄ¡´Â ¿µÇâ
°­¼öÅ£¬ ¹ÚÁ¤ÁØ£¬ À̽ÿµ£¬ ¹Ú°Ç£¬ È«±â³²£¬ ±è¼º¿í
Çѱ¹ÄÜÅ©¸®Æ®ÇÐȸ Çмú´ëȸ ³í¹®Áý, 421-424, 2008
22008
Neoadjuvant chemotherapy decreases the identification rate of sentinel lymph node biopsy
SH Kang, ES Lee, HS Kang, JS Ro, S Lee, KW Kang
Journal of Korean Breast Cancer Society 6 (2), 95-102, 2003
22003
Evaluation of base-free 11C-Raclopride synthesis with various solvents
YS Lee, JM Jeong, YH Cho, JH Lee, HJ Lee, JE Kim, YS Lee, KW Kang
Journal of Nuclear Medicine 56 (supplement 3), 2501-2501, 2015
12015
¼±Çüº¯È­¿¡ µû¸¥ ³¬½Ãº¸Æ®ÀÇ È¾¿äÀú°¨È¿°ú ¹× º¹¿ø¼º Æò°¡
Á¤ÀçÈÆ£¬ À̼ºÁ¾£¬ ¹®º´¿µ
Çѱ¹À¯Ã¼±â°èÇÐȸ ³í¹®Áý 16 (2), 5-9, 2013
12013
º¹ÇÕÀ縦 ÀÌ¿ëÇÑ ´ëÇü dz·Â ¹ßÀü¿ë Ÿ¿ö ±â¼ú°³¹ß µ¿ÇâºÐ¼®
ȫöÇö£¬ Á¤ÀçÈÆ£¬ °­º´À±£¬ ¹®º´¿µ
Çѱ¹À¯Ã¼±â°èÇÐȸ ³í¹®Áý 15 (4), 50-54, 2012
12012
Composition for preventing or treating brain cancers
JC Lee, EJ Roh, JK Choi, KS Han, JE Park, S Kang
US Patent App. 12/865,127, 2011
12011
Composition for inhibiting the activity of inositol 1, 4, 5-triphosphate receptor subtype iii
JC Lee, S Kang, KS Han, EJ Roh, JY Park
US Patent App. 12/865,128, 2011
12011
Kit for diagnosis of breast cancer using herceptin, a composition comprising herceptin and a method for detecting herceptin-sensitive her2 overexpressed cell using the same
ES Lee, KW Kang, BC Yoo, HY Lee, SY Kong, SH Kang, NS Baek, ...
US Patent App. 12/738,833, 2010
12010
º¯Ä¢ÁÖ°£ÇüÀ» °³½ÉÇü°ú Y ÀÚÇüÀ¸·Î °»½ÅÇÑ ¡®ºÎÀ¯¡¯°¨³ª¹«ÀÇ ¼öü ¹ÝÀÀ
ÃÖ¼ºÅ£¬ ±èÇбԣ¬ ±è¼ºÃ¶£¬ ÃÖÅ¹Σ¬ °­¼º¸ð£¬ ¹ÚÀ±¹®
¿ø¿¹°úÇбâ¼úÁö 24 (3), 376-381, 2006
12006
P2‐290: COMPARISON OF SELF AND INFORMANT EVALUATED KOREAN DEMENTIA SCREENING QUESTIONNAIRE COGNITION (KDSQ‐C) FOR THE DIAGNOSIS OF MILD COGNITIVE IMPAIRMENT AND DEMENTIA
DW Yang, A Kim, DW Lee, HJ Han, JH Jeong, JH Lee, JY Lee, KH Park, ...
Alzheimer's & Dementia 15, P697-P697, 2019
2019
Phenothiazine derivatives having CaM inhibitory activity
EJ Roh, BRM Jeon, CJ Lee, JP Hong, JY Jeong, SS Kang
US Patent 10,035,795, 2018
2018
[P4–246]: OBSERVATIONAL LONGITUDINAL STUDY OF BRAIN MRI CHARACTERISTICS AND CLINICAL MEASURES OF FUNCTION AND DISEASE PROGRESSION IN PATIENTS WITH DEMENTIA
KH Park, H Choi, Y Yang, JH Jeong, Brain Study group
Alzheimer's & Dementia 13 (7S_Part_28), P1372-P1372, 2017
2017
Facile synthesis of 6-[F-18] FDOPA using electrophilic substitution reaction
YH Cho, YS Lee, JH Lee, YS Lee, HJ Lee, JE Kim, KW Kang, JM Jeong
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS 58, S364-S364, 2015
2015
À¯¿¬¼¾¼­ÀÇ °ß°íÇÑ Á¢ÇÕÀ» À§ÇÑ PDMS ±â¹Ý Á÷¹°±âÆÇ Á¦ÀÛ
¹Ú¼®Èñ£¬ ¹ÚÁøÈ££¬ õ½Â¿ì£¬ ÀÌÇýÁø£¬ À̳«±Ô
Çѱ¹»ý»êÁ¦Á¶ÇÐȸ Çмú¹ßÇ¥´ëȸ ³í¹®Áý, 135-135, 2014
2014
¸ñ½Å°æ±Ùº´ÁõÀ¸·Î ÀÎÇÑ ´Ü¸¶ºñ·Î ¹ßÇöÇÑ Ã´Ãßµ¿¸Æ ¹Ú¸®Áõ
±è¼ºÈñ£¬ À±Áö¿µ£¬ ¹Ú±â´ö£¬ Á¤ÁöÇâ
The Ewha Medical Journal 37 (1), 41-45, 2014
2014
À§Çèµµ ±â¹Ý Á¢±Ù¹ý¿¡ ÀÇÇÑ ¼±¹Ú º¹¿ø¼ºÀÇ È®·ü ¿¹Ãø
¿ëÀü±º£¬ Á¤ÀçÈÆ£¬ ¹®º´¿µ
Çѱ¹À¯Ã¼±â°èÇÐȸ ³í¹®Áý 16 (2), 42-47, 2013
2013
¹Ì·¡ µµ½Ã¼ºÀå ½Ã³ª¸®¿À¿¡ µû¸¥ ¼öµµ±Ç ±âÈĺ¯È­ ¿¹Ãø º¯µ¿¼º ºÐ¼®
±èÇö¼ö£¬ Á¤ÁÖÈñ£¬ ±èÀ¯±Ù
Çѱ¹´ë±âȯ°æÇÐȸÁö (±¹¹®) 28 (3), 261-272, 2012
2012
±¤Áú¿¡ ÀÇÇÑ µé±ú Ãʱâ»ýÀ° ¹× Ç×»êÈ­ È¿°ú
À̼±¹Ì£¬ ¾ö¼®Çö
Çѱ¹¿ø¿¹ÇÐȸ Çмú¹ßÇ¥¿äÁö, 64-64, 2012
2012
ÇöÀç ½Ã½ºÅÛÀÌ ÀÛµ¿µÇÁö ¾Ê½À´Ï´Ù. ³ªÁß¿¡ ´Ù½Ã ½ÃµµÇØ ÁÖ¼¼¿ä.
ÇмúÀÚ·á 1–20